Merck Lowered the Price of Januvia—Insurers Dropped It from Formularies
March 06, 2025
In a move that should have been great news for patients, Merck significantly reduced the price of its blockbuster diabetes drug, Januvia (sitagliptin). Read More
Savings Available Now for Drugs Awaiting Medicare Price Cuts in 2027
February 12, 2025
Prescription drug costs in the U.S. remain one of the biggest financial burdens for millions of Americans—including Medicare beneficiaries. More than 5 million Medicare beneficiaries report difficulty affording their prescription medications. Read More
International Online Pharmacies Offer Relief as Medicare Prices Remain Sky-High
December 09, 2024
Another missed opportunity for the U.S. government to do right by patients struggling to afford medicines. Read More
Medicare Negotiated Drug Prices 4.7 Times Higher Than NHS Negotiated Prices
August 22, 2024
PharmacyChecker compared Medicare’s maximum fair prices for the ten selected drugs to estimates of those prices negotiated on behalf of English residents by the National Health Service (NHS) England. Read More